The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers convenient weekly dosing compared with daily basal insulin injections. EURweb on MSN: One injection could replace daily insulin for type 1 diabetes patients, researchers say *A gene therapy that may eliminate, or significantly reduce, the need for daily insulin injections is preparing to enter human trials for the first time, offering fresh hope to hundreds of thousands ... One injection could replace daily insulin for type 1 diabetes patients, researchers say For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections.
phillyvoice.com: Insulin injections could one day be replaced as a diabetes treatment with rock music, study suggests Insulin injections could one day be replaced as a diabetes treatment with rock music, study suggests Yahoo: New weekly insulin shot could replace daily injections for people with Type 2 diabetes New weekly insulin shot could replace daily injections for people with Type 2 diabetes Yahoo: Once-weekly insulin jab just as good as daily injections, trials find ZME Science: This New Peptide Could Help Millions of People Replace Insulin Injections with Daily Pills “Insulin injections remain a daily burden for many patients,” said Shingo Ito, an associate professor at Kumamoto University who led the study. “Our peptide-based platform offers a new route to ... This New Peptide Could Help Millions of People Replace Insulin Injections with Daily Pills Newswire: Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2 Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2 Nasdaq: Lilly again reduces list price of Insulin Lispro Injection as latest change to affordability options Monthly prescriptions for all Lilly insulins -- including Insulin Lispro Injection -- remain available for $35 through the Lilly Insulin Value Program and the Medicare Part D Senior Savings Model ... Lilly again reduces list price of Insulin Lispro Injection as latest change to affordability options
